Pharmacogenomics
Read the topic background here, then explore the labeled visual and structured learning explanations on this page.
Read explanation on this page ↓ See diagram ↓Pharmacogenomics — on-site reading
An introductory overview for this topic. The article introduction is reproduced here, so you do not need to leave MedAtlas to read it. It may not match the latest official medical guidance.
Pharmacogenomics, often abbreviated "PGx", is the study of the role of the genome in drug response. Its name (pharmaco- + genomics) reflects its combining of pharmacology and genomics. Pharmacogenomics analyzes how the genetic makeup of a patient affects their response to drugs. It deals with the influence of acquired and inherited genetic variation on drug response, by correlating DNA mutations (including point mutations, copy number variations, and structural variations) with pharmacokinetic (drug absorption, distribution, metabolism, and elimination), pharmacodynamic (effects mediated through a drug's biological targets), and immunogenic endpoints.
Pharmacogenomics aims to develop rational means to optimize drug therapy, with regard to the patients' genotype, to achieve maximum efficiency with minimal adverse effects. It is hoped that by using pharmacogenomics, pharmaceutical drug treatments can deviate from what is dubbed as the "one-dose-fits-all" approach. Pharmacogenomics also attempts to eliminate trial-and-error in prescribing, allowing physicians to take into consideration their patient's genes, the functionality of these genes, and how this may affect the effectiveness of the patient's current or future treatments (and where applicable, provide an explanation for the failure of past treatments). Such approaches promise the advent of precision medicine and even personalized medicine, in which drugs and drug combinations are optimized for narrow subsets of patients or even for each individual's unique genetic makeup.
Whether used to explain a patient's response (or lack of it) to a treatment, or to act as a predictive tool, it hopes to achieve better treatment outcomes and greater efficacy, and reduce drug toxicities and adverse drug reactions (ADRs). For patients who do not respond to a treatment, alternative therapies can be prescribed that would best suit their requirements. In order to provide pharmacogenomic recommendations for a given drug, two possible types of input can be used: genotyping, or exome or whole genome sequencing. Sequencing provides many more data points, including detection of mutations that prematurely terminate the synthesized protein (early stop codon).
How this connects to MD Pharmacology
Molecular investigation links DNA variation and gene regulation to RNA, proteins and cellular function. Assays measure selected molecular features with finite sensitivity and specificity; a detected variant or transcript does not automatically establish biological causation or a clinical diagnosis.
Text credit: Wikipedia contributors, “Pharmacogenomics”, original article · authors & revision history · CC BY-SA 4.0. Unmodified opening extract, accessed 24 September 2026. This Wikipedia-derived section is provided under CC BY-SA 4.0; the independent MedAtlas notes and design are separate works.
Pharmacogenomics · visual study map
Scalable vector illustration. Labeled conceptual map, not a precise anatomical, histological or diagnostic image.The wording in this learning map is adapted from the attributed Wikipedia background section below (CC BY-SA 4.0).
What the underlying subject studies
At postgraduate and higher-specialty level, begin with normal anatomy and physiology of the relevant organ system, then compare distinct disease mechanisms, their evidence base and the limitations of available investigations.
How mechanisms and evidence connect
Advanced study requires evidence appraisal, multidisciplinary interpretation and a clear distinction between established facts, hypotheses and research findings. Procedural, diagnostic and prescribing skills must be learned under an accredited program.
How to develop a sound explanation
Identify the scope of this topic within the named specialty, connect it to the applicable patient population and formulate a structured question that can be answered using current specialty literature and supervised teaching.
References and verification (optional)
All reading material on this page appears above. The links below are for checking the primary syllabus, research or source attribution, not requirements for opening this lesson.